TBPH Investing Cash Flow
Theravance Biopharma Inc · Investing Cash Flow
TBPH Investing Cash Flow
Latest reported-$107.47Mperiod ending
TBPH Cash from Investing (-$3.05M → -$107.47M)
Annual investing cash flow
High-resolution chart · PNG
TBPH investing cash flow history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| -105,284,000 | |
| 12,284,000 | |
| -32,697,000 | |
| 1,154,009,000 | |
| 124,494,000 | |
| 10,721,000 | |
| -83,051,000 | |
| 176,708,000 | |
| -56,333,000 | |
| -148,235,000 | |
| 111,039,000 | |
| -106,251,000 | |
| -2,634,000 | |
| -2,430,000 | |
| -3,052,000 |